105 related articles for article (PubMed ID: 11521224)
21. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
[TBL] [Abstract][Full Text] [Related]
23. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study.
Farley J; Smith LM; Darcy KM; Sobel E; O'Connor D; Henderson B; Morrison LE; Birrer MJ;
Cancer Res; 2003 Mar; 63(6):1235-41. PubMed ID: 12649182
[TBL] [Abstract][Full Text] [Related]
24. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
27. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer.
Müller W; Noguchi T; Wirtz HC; Hommel G; Gabbert HE
J Pathol; 1999 Oct; 189(2):186-93. PubMed ID: 10547573
[TBL] [Abstract][Full Text] [Related]
28. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
29. Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
Psyrri A; Bamias A; Yu Z; Weinberger PM; Kassar M; Markakis S; Kowalski D; Efstathiou E; Camp RL; Rimm DL; Dimopoulos MA
Clin Cancer Res; 2005 Dec; 11(23):8384-90. PubMed ID: 16322299
[TBL] [Abstract][Full Text] [Related]
30. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
31. Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma.
Hayashi H; Ito T; Yazawa T; Ikeda M; Inayama Y; Nakatani Y; Kameda Y; Nakamura N; Kitamura H
J Pathol; 2000 Sep; 192(1):26-31. PubMed ID: 10951396
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
33. p27 Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value.
Feakins RM; Ghaffar AH
Hum Pathol; 2003 Apr; 34(4):385-90. PubMed ID: 12733121
[TBL] [Abstract][Full Text] [Related]
34. Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.
Barbieri F; Cagnoli M; Ragni N; Foglia G; Bruzzo C; Pedullà F; Alama A
Clin Cancer Res; 1999 Jul; 5(7):1837-42. PubMed ID: 10430089
[TBL] [Abstract][Full Text] [Related]
35. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
Migita T; Oda Y; Naito S; Tsuneyoshi M
Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
[TBL] [Abstract][Full Text] [Related]
36. Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
Anticancer Res; 2002; 22(6A):3191-6. PubMed ID: 12530064
[TBL] [Abstract][Full Text] [Related]
37. TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins.
Bennett NA; Pattillo RA; Lin RS; Hsieh CY; Murphy T; Lyn D
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1187-93. PubMed ID: 11838966
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
[TBL] [Abstract][Full Text] [Related]
39. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
40. Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer.
Kühling H; Alm P; Olsson H; Fernö M; Baldetorp B; Parwaresch R; Rudolph P
J Pathol; 2003 Apr; 199(4):424-31. PubMed ID: 12635132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]